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Abstract
Background: Two distinct forms of atypical spongiform encephalopathies (H-BSE and L-BSE) have recently been identified
in cattle. Transmission studies in several wild-type or transgenic mouse models showed that these forms were associated
with two distinct major strains of infectious agents, which also differed from the unique strain that had been isolated from
cases of classical BSE during the food-borne epizootic disease.
Methodology/Principal Findings: H-BSE was monitored during three serial passages in C57BL/6 mice. On second passage,
most of the inoculated mice showed molecular features of the abnormal prion protein (PrP
d) and brain lesions similar to
those observed at first passage, but clearly distinct from those of classical BSE in this mouse model. These features were
similarly maintained during a third passage. However, on second passage, some of the mice exhibited distinctly different
molecular and lesion characteristics, reminiscent of classical BSE in C57Bl/6 mice. These similarities were confirmed on third
passage from such mice, for which the same survival time was also observed as with classical BSE adapted to C57Bl/6 mice.
Lymphotropism was rarely detected in mice with H-BSE features. In contrast, PrP
d was detectable, on third passage, in the
spleens of most mice exhibiting classical BSE features, the pattern being indistinguishable from that found in C57Bl/6 mice
infected with classical BSE.
Conclusion/Significance: Our data demonstrate the emergence of a prion strain with features similar to classical BSE during
serial passages of H-BSE in wild-type mice. Such findings might help to explain the origin of the classical BSE epizootic
disease, which could have originated from a putatively sporadic form of BSE.
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Introduction
The unique features of the transmissible agent involved in the
food-borne epizootic disease of bovine spongiform encephalopathy
(BSE), namely the incubation periods of the disease, the
distribution and features of the neuropathological lesions, as well
as the molecular features of the disease-associated prion protein
(PrP
d), have been characterized following transmission studies in
inbred wild-type mice [1–4]. These features, as assessed by
transmission in mice, appeared to be remarkably stable, even
following cross-species transmission from cattle to other species,
particularly that which occurred under natural conditions in
humans to produce the variant Creutzfeldt-Jakob disease (CJD), or
in some animal species such as domestic cat or goat [5–9].
However, the origin of this transmissible agent remains a mystery,
even though recycling of a scrapie agent from small ruminants has
often been suspected [10,11].
Recent studies have shown the existence of three different prion
diseases in cattle, based notably on the molecular features of the
protease-resistant prion protein (PrP
res) identified by Western blot
[12–15]. These bovine TSEs include (i) classical BSE (C-BSE),
associated with the prion strain identified during the food-borne
BSE epizootic disease in Europe since the 1980’s, (ii) H-type BSE
(H-BSE), which is an uncommon type originally described in
France [13] and (iii) L-type BSE (L-BSE), also known as bovine
amyloidotic spongiform encephalopathy (BASE), a rare form of
BSE first identified in Italy [12]. H- and L-BSE differ notably from
classical BSE by the respectively higher or lower apparent
molecular mass of unglycosylated PrP
res observed in Western blot
[15]. These two diseases have now been recognized in other
European countries [15], Japan [16] and North America [17,18],
and are suspected to represent sporadic forms of prion diseases, as
are most cases of Creutzfeldt-Jakob disease in humans [11,19]. It is
therefore probable that such cases of BSE existed before the onset
of the classical BSE epizootic disease. It has also been hypothesized
that food-borne transmission of L-BSE could have been at the
origin of the several outbreaks of transmissible mink encephalop-
athy (TME) identified since 1947 in ranch-raised mink [20].
H-BSE and L-BSE have been shown to differ between each
other and from classical BSE with respect to their incubation
periods, vacuolar pathology in the brain, and biochemical
properties of PrP
res, following transmission in transgenic mice
that express the bovine prion protein [21–25]. In addition, after
first-passage transmission of H-BSE, C57Bl/6 wild-type mice
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molecular features that characterize the disease in cattle [26,27].
In contrast, L-BSE apparently failed to transmit the disease to
C57Bl/6 or SJL wild-type mice on first passage [24]. These data
indicated that three distinct major strains of TSE agents were
involved in the three phenotypes of BSE in cattle. However,
transmission studies showed that L-BSE could acquire similar
phenotypic traits to those of the classical BSE agent, during cross-
species transmission in either inbred wild-type mouse lines [24] or
in a transgenic mouse model (tg338) over-expressing ovine PrP
[23]. This led to the hypothesis that conversion of the L-BSE
agent, resulting from passage in an intermediate host, could
explain the origin of classical BSE.
In this study, we demonstrate that although the distinct
biochemical and histopathological features of H-BSE can be
maintained for at least three passages in C57Bl/6 wild-type mice,
the emergence of classical BSE properties may occur during serial
passages in some of the animals.
Results
Primary transmission of two H-BSE isolates (01-2604 and 03-
2095) was previously reported in C57Bl/6 mice, which showed the
same molecular features of the protease-resistant prion protein
(PrP
res) in Western blot as initially described in cattle. These
features were a ,1.5 kDa higher apparent molecular mass of the
three PrP
res glycoforms compared to that found in mice infected
with a classical BSE isolate, associated with strong labeling by the
12B2 antibody in H-BSE but not in classical BSE (Figure 1A and
B, lanes 1 and 5)[27]. In addition, a C-terminally cleaved form of
PrP
res (PrP
res #2), with an unglycosylated form migrating at
,14 kDa, was identified by probing with C-terminal antibodies
such as SAF84 monoclonal antibody (Figure 1C, lanes 1 and
5)[26] and PrP
d was revealed by immunohistochemistry solely as
amyloid plaques [27].
PrP
res molecular features in the brains of H-BSE serially
passaged in C57Bl/6 mice
Transmission of the disease was then obtained on second
passage of three different H-BSE isolates in C57Bl/6 mice with
detection of the disease-associated prion protein PrP
d by Western
blot and/or immunohistochemistry in most (37/41) of the mice
inoculated with 1% brain homogenates, as shown in Table 1. The
mean mice survival periods were 560, 560 and 453 days post-
inoculation (d.p.i.) for these three H-BSE isolates i.e., 142 - 199
days less than for the primary transmissions.
On this second passage in C57Bl/6 mice using 1% brain
homogenates, similar molecular features to those described at first
passage (H-type) were observed in mice (26/26) surviving after 469
d.p.i. (Table 1 and Figure 1). However, some mice (1 and 4
respectively) in two of the three experimental groups had shorter
survival times (322-464 d.p.i.) and exhibited a strikingly different
molecular pattern, with a lower (,1.5 kDa) apparent molecular
Figure 1. Western blot analyses of brain PrP
res from mice infected with H-BSE. Mice inoculated with with H-BSE (lanes 1–3 and 5–7 from
isolates 01-2604 and 03-2095 respectively), at first (lanes 1, 5) or second passage (lanes 2–3 and 6–7), were compared to mice infected with classical
BSE (lanes 4, 8) in panels A–C. At second passage, PrP
res exhibited either H-type features, from mice that died later (491 and 504 d.p.i. in lanes 2 and 6
respectively), or ‘‘C-BSE like’’ features (464 and 322 d.p.i. in lanes 3 and 7 respectively). The brain tissue equivalents loaded per lane are indicated (in
tenth of mg). D - Glycoform proportions (means +/2 standard deviations) of PrP
res from H-BSE (isolate 03-2095)-infected mice detected using Sha31
antibody. Mice exhibited PrP
res with a molecular mass either similar to that of H-BSE (full squares) or to classical BSE (full diamonds). E - PrP
d extracted
in the absence of protease digestion and deglycosylated by PNGase treatment from H-BSE infected mice at first (lane 1) or second passage (lanes 2-3
from mice that died at 497 d.p.i. and 464 d.p.i. respectively), compared to a classical BSE control in lane 4 (0.3 mg brain tissue equivalent per lane).
Full-length PrP
d (FL) and C1 and C2 fragments are indicated. Panels A and B were revealed by monoclonal antibodies Sha31 and 12B2 respectively
and panels C and E by HRP-labelled SAF84 antibody. Bars to the left indicate the 29.0, 20.1 and 14.3 kDa marker positions.
doi:10.1371/journal.pone.0015839.g001
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res glycoforms (Figure 1A) and an absence of
labeling by 12B2 antibody (Figure 1B). No PrP
res #2 signal could
be detected using SAF84 antibody in these five mice (Figure 1C),
contrary to the mice with H-type PrP
res. In comparison to mice
with H-type features, the proportions of diglycosylated PrP
res
demonstrated by probing with Sha31 antibody, were also
increased, (Figures 1A, D). The molecular features of PrP
res in
these mice were thus indistinguishable from those of C57Bl/6
mice infected with classical BSE (‘‘C-BSE like’’).
From one of these isolates (03-2095), following inoculation of a
10% instead of a 1% brain homogenate, the mean survival period
was reduced to 362 days (Table 1) and all the mice (8/8) examined
by Western blot, that died between 253 and 427 d.p.i., showed
‘‘C-BSE like’’ features.
A third passage was also performed from this 03-2095 H-type
isolate, using 1% mouse brain homogenates that exhibited either
H-type or ‘‘C-BSE like’’ features. The resulting survival periods
were strikingly different (721+/2 121 d.p.i. and 183+/2 6 d.p.i.
respectively), and similar to those described on first passage of H-
BSE [27] and after adaptation of classical BSE [28] respectively.
All PrP
res positive mice (14/16) inoculated with H-type brain
homogenate exhibited H-type PrP
res features, whereas the
molecular features of all mice inoculated with the ‘‘C-BSE like’’
brain homogenate were indistinguishable from those of classical
BSE.
It should be noted that the PrP
res levels in mice with ‘‘C-BSE
like’’ features were much higher than in mice with H-type PrP
res
and, in this regard, were comparable to mice infected with classical
BSE, as shown by the different equivalent brain tissue masses that
needed to be loaded to obtain equivalent PrP
res signals (Figures 1A
and 1C). These differences in levels of the disease-associated PrP
accumulating in the mouse brains were also demonstrated by
analyzing brain homogenates in the absence of proteinase K (PK)
treatment (Figure 1E). After loading similar quantities of brain
equivalent tissues on each lane, cleaved PrP, corresponding to the
C2 fragment, was only abundant in mice with ‘‘C-BSE like’’
features. In mice exhibiting H-type PrP
res (i.e., all mice on first
passage and mice surviving longest on second passage), low levels
of C2 fragment were detected in addition to full length PrP and the
C1 fragment which were detected in all mice, including the non-
inoculated ones. These data suggest that the differences in PrP
res
loads between mice with H-type or ‘‘C-BSE like’’ features are not
linked to different PK sensitivities, but rather to genuine
differences in PrP
d accumulation.
PrP
res molecular features in the spleen using H-BSE
serially passaged in C57Bl/6 mice
PrP
res could not be detected by Western blot in spleens from any
of the mice infected with the 01-2604 H-BSE isolate at either 1
st or
2
nd passage, but was detected in all mice infected with the classical
BSE isolate at both passages (10/10 and 9/9 respectively)(Table 2).
Low levels of PrP
res were detected after first passage in 2/20
and 2/11 mice inoculated with the two other H-BSE isolates
(Figure 2A). After PNGase deglycosylation, the molecular masses
were higher (,0.5 kDa difference) than in mice infected with
classical BSE and comparable to those of mice infected with the
C506M3 scrapie strain (Figure 2C). In contrast to classical BSE,
PrP
res was also labeled by 12B2 antibody (data not shown).
However, we were unable to clearly identify a C-terminal PrP
res
Table 1. Bovine TSE transmission to C57Bl/6 mice. Survival periods of the animals and results of PrP
res detection and molecular
analysis by Western blot.
Survival periods Survival period according to the
Isolate Nature (mean +/- s.d., d.p.i.)
1 molecular phenotype at 2
nd passage
1
st passage 2
nd passage 3
rd passage H-type PrP
res ‘‘C-BSE like’’ PrP
res
01-2604 H-BSE 702+/2117 (8/9) 560+/284 (15/16) ND 491–763 (11)
3 464 (1)
03-1928 H-BSE 705+/296 (6/10) 560+/255 (13/15) ND 469–654 (12) (0)
744+/244 (8/13) ND ND
03-2095 H-BSE 652+/285 (10/10) 453+/290 (9/10) 183+/26 (15/16)(C)
2 492–654 (5) 322–405 (4)
721+/2121 (14/16 (H)
2
362+/2104 (10/11)
4 ND 253–427 (8)
01-2281 C-BSE 520+/284 (10/16) 208+/211 (10/20) ND ND ND
1: number of positive mice by Western blot and/or immunohistochemistry/number of mice examined.
2: (C) or (H) indicates that the mice were inoculated with a mouse brain with C-type or H-type features at second passage.
3: number of mice with the indicated PrP
res phenotype identified by Western blot.
4: inoculation of a 10% brain homogenate instead of 1% homogenates in all the other second and third passage experiments.
ND: not done.
doi:10.1371/journal.pone.0015839.t001
Table 2. Western blot detection of PrP
res into the spleens of
C57Bl/6 mice during serial passage of H-BSE.
Western blot detection of PrP
res in the spleen
1
Isolate Nature 1
st passage 2
nd passage 3
rd passage
01-2604 H-BSE 0/9 0/14 ND
03-1928 H-BSE 0/10 0/14 ND
2/10 ND ND
03-2095 H-BSE 2/11 1/10 6/7 (C)
2
0/16 (H)
2
01-2281 C-BSE 10/10 9/9 ND
1: number of Western blot positive mice/number of mice examined.
2: (C) or (H) indicates that the mice were inoculated with a mouse brain with C-
type or H-type features at second passage.
ND: not done.
doi:10.1371/journal.pone.0015839.t002
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observations on brain tissue.
After second passage, PrP
res was detected in a single mouse
inoculated with one of the three H-BSE isolates. This mouse also
had the shortest survival period (322 d.p.i.) in the experimental
group and showed ‘‘C-BSE like’’ PrP
res in the brain. The features
of PrP
res in this mouse were similar to those of mice infected with
classical BSE and migrated faster than the C506M3 scrapie
control (Figure 2C). No PrP
res could be detected in the spleens of
the four other mice with ‘‘C-BSE like’’ PrP
res in their brains. On
third passage, PrP
res was readily detected in 6/7 mice inoculated
with the brain homogenate associated with ‘‘C-BSE like’’ features
(Figure 2B). PrP
res from the spleens of these mice migrated
similarly to that of mice infected with classical BSE, as shown after
PNGase deglycosylation (Figure 2C). In contrast, PrP
res could not
be detected in the spleens of 16 mice inoculated with the H-type
brain homogenate at this third passage.
Neuropathological studies of H-BSE serially passaged in
C57Bl/6 mice
Because of the unexpected sub-group occurrence, it was not
possible to build strong brain lesion profiles with at least 5 to 6
mice for each sub-group (see supplemental data). Still the
neuropathological analysis of the H-BSE second passage experi-
ments based on PrP
d analysis offered an unequivocal evidence of
the existence of two different sub-groups of mice in two out of
three experiments. One subgroup showed the histopathological
features seen in H-BSE at first passage, and especially a low
amount of PrP
d which was exclusively detected, by Congo red
staining, as amyloid plaques (Figure 3A1, A2, C, E1, E2). The
other subgroup showed clearly distinct histopathological features.
In particular, the PrP
d deposits were much more numerous and
PrP
d brain mapping was similar in both experiments (Figure 3B
and D1). Interestingly, the types of PrP
d deposition and PrP
d brain
mapping were reminiscent of those described previously for
classical BSE in C57Bl/6 mice [29].
After a third passage, neuropathological analyses of mice
inoculated with a mouse brain homogenate exhibiting H-type
PrP
res revealed less vacuolization of the cerebellum and hypothal-
amus while the thalamus and septum presented the most severe
vacuolization (Figure S1). Notably, the cochlear nuclei were
completely unscathed (Figure 4A2). PrP
d brain mapping analyses
revealed several characteristic features: i) PrP
d accumulated almost
exclusively as plaques (Figure 4A1); ii) the brainstem, cerebellum
and cochlear nucleus (Figure 4A3) did not show any PrP
d
accumulation whereas the thalamus, midbrain and cortex
presented PrP
d plaques (Figure 4A) and iii) the rostral region of
the cortex was markedly more highly labeled.
Neuropathological analyses of mice, after third passage
transmission from a mouse with ‘‘C-BSE like’’ PrP
res, again
indicated similarities with classical BSE as illustrated by the
comparative PrP
d brain mapping (Figures 3 and 4B). Labeling of
the cochlear nucleus and cerebellum was particularly marked and
the PrP
d deposits in the latter showed the same aggregate
morphology. Nevertheless, the cortex and thalamus were less
strongly labeled in the classical BSE control and for unknown
reasons labeling of the thalamic nuclei was not identical in the two
groups.
Discussion
Our study shows that after second passage transmission of H-
BSE in C57Bl/6 mice, the features described after first passage
transmission [27] were maintained in most of the mice. The
observed mean survival periods were much longer than for
classical BSE. The phenotypic features of the disease were (1)
PrP
res of higher apparent molecular mass, associated with 12B2
labeling, indicating a different cleavage site of the protein (2)
presence of an additional C-terminal PrP
res product (PrP
res #2)
specifically detected with C-terminal antibodies (SAF84)[26] and
(3) the deposition of PrP
d, mainly in amyloid plaques, as detected
by immunohistochemistry [27]. Different strain-specific PrP
d
cleavages have also been shown between classical scrapie and
BSE. This was demonstrated in sheep using immunohistochemical
analyses of the brain [30] and, after transmission in an ovine
transgenic mouse model, by Western blot after PrP
d extraction in
the absence of any protease digestion [31]. In addition we show
here that, in contrast with classical BSE, H-BSE is poorly
lymphotropic in C57Bl/6 mice, including after serial passages.
Figure 2. Western blot analyses of PrP
res in the spleens of mice
infected with H-BSE. A - Detection of PrP
res from spleens of mice
inoculated with H-BSE isolates 01-2604 (lanes 1–3) or 03-2095 (lanes 4–9)
at first passage. B - Detection of PrP
res from spleens of mice inoculated
with H-BSE at third passage in mice inoculated with a brain homogenate
with ‘‘C-BSE like’’ PrP
res (lanes 4–8). PrP
res from the brain of one of these
mice (lanes 3, 9) and from brains of C506M3 scrapie (lanes 1, 11) or
classical BSE (lanes 2, 10) controls are shown for comparison. C - PrP
res
from spleens of mice infected with H-BSE at first passage (lanes 2,
4)(isolates 03-1928 and03-2095), second passage in a mouse with ‘‘C-BSE
like’’ PrP
res (lane 6) and third passage from mice inoculated with a brain
homogenate with ‘‘C-BSE like’’ PrP
res (lanes 8, 10). PrP
res from spleens of
classicalBSE(lanes3,5,7, 9)andC506M3(lanes1,11)controls areshown.
PanelsAandBwererevealedbymonoclonalantibodySha31andpanelC
by HRP-labelled SAF84 antibody Bars to the left indicate the 29.0 and
20.1 kDa marker positions in panels A and B or the 20.1 and 14.3 kDa
marker positions in panels C and D.
doi:10.1371/journal.pone.0015839.g002
H-BSE and Classical BSE
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mice, which also exhibited shorter survival periods, after this
second passage of H-BSE in C57Bl/6 mice. These features
included (1) a similar apparent molecular mass of PrP
res to that
found in mice infected with classical BSE [32] and the absence of a
C-terminal PrP
res product detected by SAF84 antibody [26] and
(2) lesions of vacuolar degeneration and patterns of PrP
d
deposition characteristic of classical BSE previously described in
these mice [29,33]. After a third passage, using mouse brains with
‘‘C-BSE like’’ features, the biochemical and histopathological
similarities with classical BSE were confirmed, whereas the
characteristics of H-BSE were maintained in mice inoculated
with a brain homogenate containing H-type PrP
res. In addition,
most (6/7) of the mice inoculated with a brain homogenate with
‘‘C-BSE like’’ features were positive in the spleen and showed
similar features to those found with classical BSE, in contrast with
mice with H-type PrP
res at third passage.
Our data demonstrate the emergence of phenotypic features
similar to those of classical BSE after cross-species transmission of
an atypical form of BSE and are reminiscent of those previously
described for the other form of atypical BSE, i.e., BASE or L-BSE
[24]. L-BSE otherwise shows clearly distinct features from H-BSE,
both in cattle and after transmission in different transgenic mouse
models, thereby indicating that the two atypical forms of BSE
involve two distinct major strains, both of which differ from the
strain involved in classical BSE [12,15,21–23,34]. It is thus
Figure 3. Histopathological analyses of mice infected with H-BSE at second passage. Brain distribution of the disease-associated prion
protein (PrP
d) observed in the brain of C57Bl/6 mice infected with 3 isolates of H-BSE, at second passage. The green color gives the schematic
representation of PrP
d, the dots symbolize the plaque type deposits. Plaques of amyloid nature as revealed by a Red Congo staining observed under
polarized light (A2 & D3) and made of PrPd deposits (A1, D2, E1, E2) (black staining after IHC) were similarly detected in each H- BSE transmission
studies and remarkably this amyloid type of PrP
d deposition was the predominant histopathological features typical of H-BSE. In two out of three
second passage experiments, another sub-group of mice was clearly identified as showing a different PrP
d brain mapping. This sub-group showed
much more brain areas accumulating PrP
d with a granular type of staining (B, D1), reminding most of the features seen in the case of the classical BSE
features (F1, F3) of which also typical spongiform changes in the cochlear nucleus (F2).
doi:10.1371/journal.pone.0015839.g003
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phenotypic features to those of classical BSE after cross-species
transmission in wild-type mice. The L-BSE study, which involved
monitoring a single L-BSE isolate during two passages in C57Bl/6
and SJL wild-type mice and a single passage in RIII and VM mice,
nevertheless differed from our study on several points. The mice
were inoculated by both intra-cerebral and intra-peritoneal routes,
from a bovine thalamus sample at first passage and from pools of
brains from C57Bl/6 or SJL mice at second passage. No evidence
of disease transmission was found on first passage [24], although
trace amounts of PrP
res were reported in a single RIII mouse that,
interestingly, showed biochemical properties identical to those of
classical BSE-infected mice. The situation in our experiments was
different since H-BSE was able to transmit the disease to C57Bl/6
mice after first passage, with accumulation of PrP
d in the brain.
Mice with ‘‘C-BSE like’’ characteristics were identified at the
second passage, that showed the shortest survival times (322-464
days post-inoculation (d.p.i.)), as compared with the survival times
of 258-331 d.p.i. reported after second passage in C57Bl/6 mice,
with a L-BSE isolate [24]. However, the other mice in our
experiments developed H-BSE and exhibited longer survival
periods (. 491 d.p.i.), and similar biochemical and histopatho-
logical features to those observed at first passage. The explanation
of shortened survivals of mice at this second passage is unclear, but
it does not seem to reflect an adaptation of the H-type BSE agent
in C57Bl/6 mice since the survival of mice that showed H-type
features at third passage was longer. Both Western blot and
histopathological analyses demonstrated the maintenance of
similar features (either H-type or ‘‘C-BSE’’ like’’), after third
passage, in all mice inoculated with either one of the two
phenotypes. The above observations suggest the existence of a
divergence phenomenon whereby the H-BSE properties are
maintained in only some of the infected mice during serial
passages, possibly as a result of the coexistence of both agents and
competition between them. Further investigations are required to
determine the level of interference between the two agents that are
able to propagate in C57Bl/6 mice.
However, the emergence of phenotypic properties similar to
classical BSE in some C57Bl/6 mice infected with H-BSE in our
study was observed in only two out of three experiments involving
the three isolates. Although the possibility of cross-contamination
with classical BSE cannot be excluded unequivocally as classical
BSE has been handled in our laboratories, the occurrence of
cross-contamination is highly unlikely as we have implemented
rigorous laboratory practices and there has been no evidence of
cross- contamination in previous experiments that have been
conducted in our laboratory. The possibility that the observations
might be influenced by the precise neuro-anatomical origin of the
inoculated bovine brain stem homogenate cannot be excluded.
We can however hypothesize that classical BSE might represent a
minor sub-population of the TSE agents present in atypical H-
BSE which could be selected by serial passages in wild-type mice.
Alternatively, a TSE strain similar to classical BSE might be
produced de novo during cross-species transmission of H-BSE
prions in wild-type mice. Such observations are not unprece-
dented and can be compared to the sudden and discontinuous
changes observed in some scrapie strains with Class III stability,
such as the 87A scrapie strain in C57BL mice. In some
experiments, 40% and 100% of the mice inoculated with 1%
and 10% wt/vol brain homogenates respectively showed much
shorter incubation periods, at all stages between primary and
seventh passage. Serial passages from such mice consistently led
to isolation of a novel strain (7D) with stable incubation periods
and distinct neuropathological features, indistinguishable from
those of the ME7 scrapie strain [35]. These observations were
interpreted as evidence of a mutation of the scrapie agent.
Another example has been the identification of two distinct
strains (HY and DY) from transmissible mink encephalopathy
after serial passages in hamster, which was interpreted as
selection of strains from a mixture [36]. Further studies of the
possible effects of inocula concentrations and serial passages are
thus required in the case of H-BSE, to better understand the
similar ‘‘breakdown’’ phenomenon [35] that was observed in our
study. Interestingly an experiment of a second passage of H-type
BSE using a more highly concentrated (10%) brain homogenate,
from a mouse brain that had already provided evidence of C-BSE
emergence as 1% brain homogenate, favored the propagation of
the ‘‘C-BSE like’’ agent.
Figure 4. Histopathological analyses of mice infected with H-BSE at third passage. Brain distribution of the disease-associated prion
protein (PrP
d) observed in the brain of C57Bl/6 mice infected with H-BSE, at third passage from a mouse with H-type features (A) or with ‘‘C-BSE like’’
features (B). The green color gives the schematic representation of PrP
d, the dots symbolize the plaque type deposits. In right panels, pictures of
some characteristics PrP
d deposits for 3
rd passage of H-BSE from mouse with H-type features in thalamus as plaques solely (A1) or from mouse with C-
type features in the cortex (B1). The cochlear nucleus showed spongiform lesions (B2 compared to A2) and granular PrP
d brain deposits (dark
deposits of DAB intensified using NiCl2) (B3 compared to A3) in the C-type solely. Scale bars: 50 mm for all panels and 10 mm for the plaque focus in
panel A1.
doi:10.1371/journal.pone.0015839.g004
H-BSE and Classical BSE
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relationship existing between - most probably sporadic - forms of
atypical BSE and the food-borne epizootic disease of classical BSE
in cattle.
Materials and Methods
Ethics statement
Experiments were performed in the approved experimental
facilities (A3) of the author’s institution (nu A 69 387 081) with the
approval of the Rho ˆne-Alpes Ethical Committee for Animal
Experiments (CREEA nu98) and following the guidelines of the
French Ethical Committee (decree 87-848) and European
Community Directive 86/609/EEC.
Bovine TSE isolates
Cattle TSE isolates included 3 H-BSE isolates and 1 classical
BSE isolate, based on the molecular analyses of PrP
res
(Table 1)[13]. Features of the disease and PrP
res molecular
features after a primary passage in C57Bl/6 mice have previously
been described for two of the H-BSE and for the classical BSE
isolate [26,27].
Transmission studies in mice
For serial passages, four-to-six weeks old female mice (15–20
animals per experimental group) were inoculated intra-cerebrally
with 1% (wt/vol) brain homogenates in 5% glucose (20 ml per
animal) from mice at 1
st or 2
nd passage. Mice were followed twice
weekly and at the terminal stage of disease or end of life, brains
were collected and either analysed, from frozen samples, by
Western Blot, or from fixed samples in buffered 10% formalin, by
histology and immunohistochemistry. Spleens were frozen for
Western blot analysis.
Western blot analyses of PrP
res and PrP
d
The extraction methods used to identify and characterize the
proteinase K (PK) resistant prion protein (PrP
res)f r o mm o u s e
brains have been previously described [26,37]. Briefly, PrP
res was
obtained following treatment of mouse brain homogenates with
PK (Roche)(10 mg/100 mg brain tissue for 1 h at 37uC) and
concentration by ultra-centrifuging (100 000 rpm for 2 hours on
a 10% sucrose cushion). Disease-associated PrP (PrP
d) isolated
from the brains of mice was also prepared for Western blot
analyses in the absence of PK treatment, and was isolated as
previously described for PrP
res, but the PK digestion step was
omitted [31]. For spleen samples PrP
res was extracted from the
entire spleens by treating the spleen homogenates with collage-
nase (100 mg/100 mg spleen in a 1 ml total volume) and DNAse
(64 mg/100 mg spleen in a 1 ml total volume) for 1 h at 37uC,
then with PK (24 mg/100 mg spleen in a 1.2 ml volume) for 1 h
at 37uC [38]. In some experiments deglycosylation was
performed using PNGase F (kit P07043, BioLabs). Denatured
samples of PrP
res in TD4215 buffer (4% sodium dodecyl sulfate,
2% b-mercaptoethanol, 192 mM glycine, 25 mM Tris, 5%
sucrose)(1–2 ml) were mixed with denaturing buffer from the
PNGase kit, G7 buffer, NP40 and PNGase according to the
manufacturer’s instructions. After incubation at 37uC for 1 h,
samples were ready for Western blot analysis following appro-
priate dilution in TD4215 buffer.
After heat denaturation for 5 min at 100uC in TD4215 buffer,
PrP was separated in 15% SDS-PAGE and electroblotted on to
nitrocellulose membranes, then detected on the membrane using
anti-PrP monoclonal antibodies. PrP
res or PrP
d were detected
using the monoclonal antibodies anti-PrP Sha31 (1/10 from kit
TeSeE sheep/goat Biorad), SAF84 (500 ng/ml)(SPI-Bio, France)
or 12B2 (340 ng/ml) against the 144-WEDRYYRE-151, 163-
RPVDQY-168 and 88-WGQGG-92 murine PrP sequences
respectively. Peroxidase-labelled conjugate anti-mouse IgG
(H+L)(1/2500 in PBST)(ref 1010-05)(Clinisciences, France) was
used to detect Sha31 and 12B2 antibodies, whereas SAF84 was
used as horseradish peroxidase antibody. Quantitative studies of
PrP
res polypeptide molecular mass and glycoforms proportions
were performed using Quantity One (Biorad) software analysis of
chemiluminescent signals. Glycoforms ratios were expressed as
mean percentages (+/2 standard deviations) of the total signal for
the three PrP
res glycoforms and the apparent molecular masses
were evaluated by comparison of the positions of the PrP
res bands
with a biotinylated marker (B2787, Sigma).
Histopathological analyses
Mouse brains fixed in buffered 10% formalin solution were
treated for 1 hour at room temperature (RT) with formic acid
(98–100%) before embedding in paraffin blocks (Thermo
Electron, Cergy-Pontoise, France). Tissue sections five microme-
ters thick were cut from paraffin blocks, placed on treated glass
slides (Starfrost, Medite Histotechnic, Burgdorf, Germany) and
dried overnight at 55uC. Once dewaxed, the slides were stained
for either histopathological or immunohistochemical examina-
tion. Amyloid deposits were identified with a Congo red stain,
and vacuolar lesions were observed on slides stained with
hematoxylin-eosin (HE) according to Fraser’s lesion profile
analyses [39]. Lesion profiles were measured using a computer-
assisted method [40]. For immunohistochemistry, brain slices
were immunostained for the presence of disease-associated prion
protein (PrP
d) using 2 mg/ml of anti-PrP SAF84 monoclonal
antibody (SPI Bio, France) [41]. Recently described pre-
treatments designed to enhance PrP
d detection were also applied
[42]. These consisted of a 10 min formic acid (98%) bath at room
temperature, 20 min hydrated autoclaving at 121uC (Prestige
Medical, AES Labs, Blackburn Lane, UK) and digestion at 37uC
with PK (Roche Diagnostics, Meylan, France) at a concentration
of 20 mg/ml for 15 min, with an additional incubation with
streptomycin sulfate at 8.75 mg/ml for 1 hour. Endogenous
peroxidase activity was also blocked. A peroxidase-labelled
avidin-biotin complex (Vectastain Elite ABC, Vector Laborato-
ries, Burlingame, CA) and a solution of diaminobenzidine
intensified with nickel chloride (DAB-Ni, Zymed, France) to give
black deposits was used to amplify and visualize PrP
d binding.
The specificity of PrP
d immunolabelling was also assessed using
uninfected brain sections. Finally, the slides were counterstained
with aqueous hematoxylin, dehydrated, mounted using Eukitt
and observed under a light microscope BX51 (Olympus, France)
coupled to an image analysis workstation (MorphoExpert
software, Explora Nova, La Rochelle, France).
Supporting Information
Figure S1 Vacuolar lesion profiles observed in the brain of
C57Bl/6 mice infected with 3 isolates of H-BSE, at second
passage, and for one isolate at third passage from a mouse with H-
type features or with ‘‘C-BSE like’’ features. Brain vacuolation was
scored (means 6 standard deviations) on a scale of 0–5 in the
following brain areas: 1) dorsal medulla nuclei, 2) cerebellar
cortex, 3) superior colliculus, 4) hypothalamus, 5) central thalamus,
6) hippocampus, 7) lateral septal nuclei, 8) cerebral cortex at the
level of thalamus, and 9) cerebral cortex at the level of septal
nuclei.
(TIF)
H-BSE and Classical BSE
PLoS ONE | www.plosone.org 7 January 2011 | Volume 6 | Issue 1 | e15839Acknowledgments
We are grateful to Dominique Canal for her contribution to Western blot
studies and for preparing the animal experiments, Ce ´line Raynaud and
Mikae ¨l Leboidre for the histotechnical analyses, Emilie Antier for the
follow-up of animal experiments, as well as Diana Warwick for careful
revision of the English language.
Author Contributions
Conceived and designed the experiments: TB AB. Performed the
experiments: JVulin LL JVerchere. Analyzed the data: TB JVulin
JVerchere AB. Contributed reagents/materials/analysis tools: AGB. Wrote
the paper: TB JMT AB.
References
1. Fraser H, Bruce ME, Chree A, McConnell I, Wells GA (1992) Transmission of
bovine spongiform encephalopathy and scrapie to mice. J Gen Virol 73:
1891–1897.
2. Bruce ME (1996) Strain typing studies of scrapie and BSE. In Baker H,
Ridley RM, eds. Prion diseases Totowa, NJ: Humana Press. pp 223–236.
3. Somerville RA, Chong A, Mulqueen OU, Birkett CR, Wood SC, et al. (1997)
Biochemical typing of scrapie strains. Nature 386: 564.
4. Kuczius T, Haist I, Groschup MH (1998) Molecular analysis of bovine
spongiform encephalopathy and scrapie strain variation. J Infect Dis 178:
693–699.
5. Bruce M, Chree A, McConnell I, Foster J, Pearson G, et al. (1994) Transmission
of bovine spongiform encephalopathy and scrapie to mice: strain variation and
the species barrier. Philos Trans R Soc Lond B Biol Sci 343: 405–411.
6. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, et al. (1997)
Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE
agent. Nature 389: 498–501.
7. Green R, Horrocks C, Wilkinson A, Hawkins SA, Ryder SJ (2005) Primary
isolation of the bovine spongiform encephalopathy agent in mice: agent
definition based on a review of 150 transmissions. J Comp Pathol 132: 117–131.
8. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF (1996) Molecular analysis of
prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383:
685–690.
9. Eloit M, Adjou K, Coulpier M, Fontaine JJ, Hamel R, et al. (2005) BSE agent
signatures in a goat. Vet Rec 156: 523–524.
10. Wilesmith JW, Wells GA, Cranwell MP, Ryan JB (1988) Bovine spongiform
encephalopathy: epidemiological studies. Vet Rec 123: 638–644.
11. Baron T, Biacabe AG (2006) Origin of bovine spongiform encephalopathy.
Lancet 367: 297–298; author reply 298-299.
12. Casalone C, Zanusso G, Acutis P, Ferrari S, Capucci L, et al. (2004)
Identification of a second bovine amyloidotic spongiform encephalopathy:
molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad
Sci U S A 101: 3065–3070.
13. Biacabe AG, Laplanche JL, Ryder S, Baron T (2004) Distinct molecular
phenotypes in bovine prion diseases. EMBO Rep 5: 110–115.
14. Baron T, Biacabe AG, Arsac JN, Benestad S, Groschup MH (2007) Atypical
transmissible spongiform encephalopathies (TSEs) in ruminants. Vaccine 25:
5625–5630.
15. Jacobs JG, Langeveld JP, Biacabe AG, Acutis PL, Polak MP, et al. (2007)
Molecular discrimination of atypical bovine spongiform encephalopathy strains
from a geographical region spanning a wide area in Europe. J Clin Microbiol 45:
1821–1829.
16. Hagiwara K, Yamakawa Y, Sato Y, Nakamura Y, Tobiume M, et al. (2007)
Accumulation of mono-glycosylated form-rich, plaque-forming PrPSc in the
second atypical bovine spongiform encephalopathy case in Japan. Jpn J Infect
Dis 60: 305–308.
17. Richt JA, Kunkle RA, Alt D, Nicholson EM, Hamir AN, et al. (2007)
Identification and characterization of two bovine spongiform encephalopathy
cases diagnosed in the United States. J Vet Diagn Invest 19: 142–154.
18. Dudas S, Yang J, Graham C, Czub M, McAllister TA, et al. (2010) Molecular,
biochemical and genetic characteristics of BSE in Canada. PLoS ONE 5:
e10638.
19. Biacabe AG, Morignat E, Vulin J, Calavas D, Baron TG (2008) Atypical bovine
spongiform encephalopathies, France, 2001-2007. Emerg Infect Dis 14:
298–300.
20. Baron T, Bencsik A, Biacabe AG, Morignat E, Bessen RA (2007) Phenotypic
similarity of transmissible mink encephalopathy in cattle and L-type bovine
spongiform encephalopathy in a mouse model. Emerg Infect Dis 13: 1887–1894.
21. Buschmann A, Gretzschel A, Biacabe AG, Schiebel K, Corona C, et al. (2006)
Atypical BSE in Germany–proof of transmissibility and biochemical character-
ization. Vet Microbiol 117: 103–116.
22. Beringue V, Bencsik A, Le Dur A, Reine F, Lai TL, et al. (2006) Isolation from
cattle of a prion strain distinct from that causing bovine spongiform
encephalopathy. PLoS Pathog 2: e112.
23. Beringue V, Andreoletti O, Le Dur A, Essalmani R, Vilotte JL, et al. (2007) A
bovine prion acquires an epidemic bovine spongiform encephalopathy strain-like
phenotype on interspecies transmission. J Neurosci 27: 6965–6971.
24. Capobianco R, Casalone C, Suardi S, Mangieri M, Miccolo C, et al. (2007)
Conversion of the BASE prion strain into the BSE strain: the origin of BSE?
PLoS Pathog 3: e31.
25. Okada H, Masujin K, Imamaru Y, Imamura M, Matsuura Y, et al. (2010)
Experimental transmission of H-type bovine spongiform encephalopathy to
bovinized transgenic mice. Vet Pathol doi:10.1177/0300985810382672.
26. Biacabe AG, Jacobs JG, Bencsik A, Langeveld JP, Baron TG (2007) H-type
bovine spongiform encephalopathy: complex molecular features and similarities
with human prion diseases. Prion 1: 61–68.
27. Baron TG, Biacabe AG, Bencsik A, Langeveld JP (2006) Transmission of new
bovine prion to mice. Emerg Infect Dis 12: 1125–1128.
28. Lasmezas CI, Deslys JP, Demaimay R, Adjou KT, Hauw JJ, et al. (1996) Strain
specific and common pathogenic events in murine models of scrapie and bovine
spongiform encephalopathy. J Gen Virol 77: 1601–1609.
29. Lezmi S, Bencsik A, Baron T (2006) PET-blot analysis contributes to BSE strain
recognition in C57Bl/6 mice. J Histochem Cytochem 54: 1087–1094.
30. Jeffrey M, Gonzalez L, Chong A, Foster J, Goldmann W, et al. (2006) Ovine
infection with the agents of scrapie (CH1641 isolate) and bovine spongiform
encephalopathy: immunochemical similarities can be resolved by immunohis-
tochemistry. J Comp Pathol 134: 17–29.
31. Nicot S, Baron TG (2010) Strain-specific proteolytic processing of the prion
protein in prion diseases of ruminants transmitted in ovine transgenic mice.
J Gen Virol 91: 570–574.
32. Baron TG, Biacabe AG (2001) Molecular analysis of the abnormal prion protein
during coinfection of mice by bovine spongiform encephalopathy and a scrapie
agent. J Virol 75: 107–114.
33. Brown DA, Bruce ME, Fraser JR (2003) Comparison of the neuropathological
characteristics of bovine spongiform encephalopathy (BSE) and variant
Creutzfeldt-Jakob disease (vCJD) in mice. Neuropathol Appl Neurobiol 29:
262–272.
34. Lombardi G, Casalone C, D’Angelo A, Gelmetti D, Torcoli G, et al. (2008)
Intraspecies transmission of BASE induces clinical dullness and amyotrophic
changes. PLoS Pathog 4: e1000075.
35. Bruce ME, Dickinson AG (1987) Biological evidence that scrapie agent has an
independent genome. J Gen Virol 68: 79–89.
36. Bessen RA, Marsh RF (1992) Identification of two biological distinct strains of
transmissible mink encephalopathy in hamsters. J Gen Virol 73: 329–334.
37. Baron T, Bencsik A, Vulin J, Biacabe AG, Morignat E, et al. (2008) A C-
terminal protease-resistant prion fragment distinguishes ovine ‘‘CH1641-like’’
scrapie from bovine classical and L-Type BSE in ovine transgenic mice. PLoS
Pathog 4: e1000137.
38. Baron T, Bencsik A, Morignat E (2010) Prions of ruminants show distinct
splenotropisms in an ovine transgenic mouse model. PLoS ONE 5: e10310.
39. Fraser H, Dickinson AG (1968) The sequential development of the brain lesion
of scrapie in three strains of mice. J Comp Pathol 78: 301–311.
40. Bencsik A, Philippe S, Vial L, Calavas D, Baron T (2005) Automatic
quantitation of vacuolar lesions in the brain of mice infected with transmissible
spongiform encephalopathies. J Virol Methods 124: 197–202.
41. Bencsik A, Philippe S, Debeer S, Crozet C, Calavas D, et al. (2007) Scrapie
strain transmission studies in ovine PrP transgenic mice reveal dissimilar
susceptibility. Histochem Cell Biol 127: 531–539.
42. Bencsik AA, Coleman AW, Debeer SO, Perron H, Moussa A (2006) Amplified
immunohistochemical detection of PrPsc in animal transmissible spongiform
encephalopathies using streptomycin. J Histochem Cytochem 54: 849–853.
H-BSE and Classical BSE
PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e15839